{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:36:34Z","timestamp":1790620594478,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11936-019-0751-2","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T02:03:27Z","timestamp":1564020207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CRT Optimization: What Is New? What Is Necessary?"],"prefix":"10.1007","volume":"21","author":[{"given":"Jeroen","family":"Dauw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"issue":"29","key":"751_CR1","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281\u2013329.","journal-title":"Eur Heart J"},{"issue":"14","key":"751_CR2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIR.0b013e3182618569","volume":"126","author":"CM Tracy","year":"2012","unstructured":"Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, et al. 2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012;126(14):1784\u2013800.","journal-title":"Circulation."},{"issue":"19","key":"751_CR3","first-page":"1463","volume":"38","author":"C Daubert","year":"2017","unstructured":"Daubert C, Behar N, Martins RP, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017;38(19):1463\u201372.","journal-title":"Eur Heart J"},{"issue":"26","key":"751_CR4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441\u20136.","journal-title":"N Engl J Med"},{"issue":"7","key":"751_CR5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jacc.2008.08.079","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Verga T, Grimm RA, Starling RC, Wilkoff BL, Tang WHW. Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J Am Coll Cardiol. 2009;53(7):600\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"751_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehi446","volume":"27","author":"FA McAlister","year":"2006","unstructured":"McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B, et al. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J. 2006;27(3):323\u20139.","journal-title":"Eur Heart J"},{"issue":"4","key":"751_CR7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ejhf.929","volume":"20","author":"LH Lund","year":"2018","unstructured":"\u2022 Lund LH, Svennblad B, Dahlstrom U, Stahlberg M. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure. Eur J Heart Fail. 2018;20(4):769\u201377 Good overview on evolution of guidelines and effect on CRT eligibility.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"751_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstrom U, Filippatos G, Ponikowski P, Zannad F, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173\u201384.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"751_CR9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","volume":"19","author":"LH Lund","year":"2017","unstructured":"Lund LH, Braunschweig F, Benson L, Stahlberg M, Dahlstrom U, Linde C. Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry. Eur J Heart Fail. 2017;19(10):1270\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"751_CR10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2016.11.043","volume":"119","author":"PH Pun","year":"2017","unstructured":"Pun PH, Sheng S, Sanders G, DeVore AD, Friedman D, Fonarow GC, et al. Prescription of guideline-recommended implantable cardioverter defibrillator and cardiac resynchronization therapy among patients hospitalized with heart failure and varying degrees of renal function. Am J Cardiol. 2017;119(6):886\u201392.","journal-title":"Am J Cardiol"},{"issue":"11","key":"751_CR11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993\u20131004.","journal-title":"N Engl J Med"},{"issue":"9","key":"751_CR12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cardfail.2014.06.005","volume":"20","author":"RM Gage","year":"2014","unstructured":"Bank AJ, Gage RM, Olshansky B. On the underutilization of cardiac resynchronization therapy. J Card Fail. 2014;20(9):696\u2013705.","journal-title":"J Card Fail"},{"issue":"1","key":"751_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCHEARTFAILURE.113.000789","volume":"7","author":"JE Wilcox","year":"2014","unstructured":"Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, et al. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014;7(1):146\u201353.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"751_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/ejhf.1142","volume":"20","author":"K Dickstein","year":"2018","unstructured":"Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. 2018;20(6):1039\u201351.","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"751_CR15","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/eurheartj\/ehx100","volume":"38","author":"SM Hosseini","year":"2017","unstructured":"\u2022 Hosseini SM, Moazzami K, Rozen G, Vaid J, Saleh A, Heist KE, et al. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013. Eur Heart J. 2017;38(27):2122-8\u2013 Very contemporary data on real world CRT use.","journal-title":"Eur Heart J"},{"issue":"1","key":"751_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCULATIONAHA.113.006124","volume":"130","author":"J Steffel","year":"2014","unstructured":"Steffel J, Ruschitzka F. Superresponse to cardiac resynchronization therapy. Circulation. 2014;130(1):87\u201390.","journal-title":"Circulation."},{"issue":"19","key":"751_CR17","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jacc.2017.03.531","volume":"69","author":"EP Zeitler","year":"2017","unstructured":"\u2022\u2022 Zeitler EP, Friedman DJ, Daubert JP, Al-Khatib SM, Solomon SD, Biton Y, et al. Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up. J Am Coll Cardiol. 2017;69(19):2369\u201379 This post-hoc analysis of the landmark MADIT-CRT trial, illustrates how comorbidities influence survival and heart failure hospitalizations after CRT. A higher comorbity burden impaires outcome in general. However when compared according to the number of comorbidities CRT improves outcome in every category.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"751_CR18","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","volume":"117","author":"ES Chung","year":"2008","unstructured":"Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608\u201316.","journal-title":"Circulation"},{"issue":"15","key":"751_CR19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","volume":"369","author":"F Ruschitzka","year":"2013","unstructured":"Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369(15):1395\u2013405.","journal-title":"N Engl J Med"},{"issue":"6","key":"751_CR20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ahj.2007.07.039","volume":"154","author":"W Mullens","year":"2007","unstructured":"Mullens W, Tang WH, Grimm RA. Using echocardiography in cardiac resynchronization therapy. Am Heart J. 2007;154(6):1011\u201320.","journal-title":"Am Heart J"},{"issue":"7","key":"751_CR21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1540-8167.2009.01444.x","volume":"20","author":"LA Saxon","year":"2009","unstructured":"Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol. 2009;20(7):764\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"21","key":"751_CR22","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/eurheartj\/ehr505","volume":"33","author":"C Thebault","year":"2012","unstructured":"Thebault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012;33(21):2662\u201371.","journal-title":"Eur Heart J"},{"issue":"11","key":"751_CR23","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacep.2018.07.006","volume":"4","author":"V Kutyifa","year":"2018","unstructured":"\u2022 Kutyifa V, Kosztin A, Klein HU, Biton Y, Nagy VK, Solomon SD, et al. Left ventricular lead location and long-term outcomes in cardiac resynchronization therapy patients. JACC Clin Electrophysiol. 2018;4(11):1410\u201320 Recent long-term follow-up data on patient outcomes according to lead location from the landmark MADIT-CRT trial.","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"751_CR24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjcard.2005.04.045","volume":"96","author":"EK Heist","year":"2005","unstructured":"Heist EK, Fan D, Mela T, Arzola-Castaner D, Reddy VY, Mansour M, et al. Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy. Am J Cardiol. 2005;96(5):685\u201390.","journal-title":"Am J Cardiol"},{"issue":"11","key":"751_CR25","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.hrthm.2015.05.020","volume":"12","author":"G Stabile","year":"2015","unstructured":"Stabile G, D\u2019Onofrio A, Pepi P, De Simone A, Santamaria M, Caico SI, et al. Interlead anatomic and electrical distance predict outcome in CRT patients. Heart Rhythm. 2015;12(11):2221\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"751_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/heart.90.1.17","volume":"90","author":"JW Fung","year":"2004","unstructured":"Fung JW, Yu CM, Yip G, Zhang Y, Chan H, Kum CC, et al. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart. 2004;90(1):17\u20139.","journal-title":"Heart."},{"issue":"20","key":"751_CR27","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/eurheartj\/ehr329","volume":"32","author":"MR Gold","year":"2011","unstructured":"Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J. 2011;32(20):2516\u201324.","journal-title":"Eur Heart J"},{"issue":"29","key":"751_CR28","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/eht123","volume":"34","author":"J Kandala","year":"2013","unstructured":"Kandala J, Upadhyay GA, Altman RK, Parks KA, Orencole M, Mela T, et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J. 2013;34(29):2252\u201362.","journal-title":"Eur Heart J"},{"issue":"5","key":"751_CR29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCEP.115.003004","volume":"8","author":"T Roubicek","year":"2015","unstructured":"Roubicek T, Wichterle D, Kucera P, Nedbal P, Kupec J, Sedlakova J, et al. Left ventricular lead electrical delay is a predictor of mortality in patients with cardiac resynchronization therapy. Circ Arrhythm Electrophysiol. 2015;8(5):1113\u201321.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"751_CR30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/ehf2.12340","volume":"5","author":"JP Singh","year":"2018","unstructured":"Singh JP, Berger RD, Doshi RN, Lloyd M, Moore D, Daoud EG, et al. Rationale and design for ENHANCE CRT: QLV implant strategy for non-left bundle branch block patients. ESC Heart Fail. 2018;5(6):1184\u201390.","journal-title":"ESC Heart Fail"},{"issue":"17","key":"751_CR31","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2011.12.030","volume":"59","author":"FZ Khan","year":"2012","unstructured":"Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59(17):1509\u201318.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"751_CR32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCHEARTFAILURE.112.000078","volume":"6","author":"S Saba","year":"2013","unstructured":"Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White P, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail. 2013;6(3):427\u201334.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"751_CR33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchf.2013.11.010","volume":"2","author":"AC Kydd","year":"2014","unstructured":"Kydd AC, Khan FZ, Watson WD, Pugh PJ, Virdee MS, Dutka DP. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy). JACC Heart Fail. 2014;2(3):205\u201312.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"751_CR34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.echo.2014.01.025","volume":"27","author":"LE Sade","year":"2014","unstructured":"Sade LE, Saba S, Marek JJ, Onishi T, Schwartzman D, Adelstein EC, et al. The association of left ventricular lead position related to regional scar by speckle-tracking echocardiography with clinical outcomes in patients receiving cardiac resynchronization therapy. J Am Soc Echocardiogr. 2014;27(6):648\u201356.","journal-title":"J Am Soc Echocardiogr"},{"key":"751_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1532-429X-13-29","volume":"13","author":"F Leyva","year":"2011","unstructured":"Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:29.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"751_CR36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ejhf.661","volume":"18","author":"J Gorcsan 3rd","year":"2016","unstructured":"Gorcsan J 3rd. Multimodality lead positioning for cardiac resynchronization therapy: how much imaging do we need? Eur J Heart Fail. 2016;18(11):1383\u20135.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"751_CR37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacep.2015.10.004","volume":"2","author":"G Boriani","year":"2016","unstructured":"\u2022\u2022 Boriani G, Connors S, Kalarus Z, Lemke B, Mullens W, Osca Asensi J, et al. Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: results of the MORE-CRT randomized trial. JACC Clin Electrophysiol. 2016;2(2):212\u201320 First large randomized trial on quadripolar leads, indicating superiority in terms of complication rate compared to bipolar leads.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"751_CR38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacep.2016.02.007","volume":"2","author":"MP Turakhia","year":"2016","unstructured":"Turakhia MP, Cao M, Fischer A, Nabutovsky Y, Sloman LS, Dalal N, et al. Reduced mortality associated with quadripolar compared to bipolar left ventricular leads in cardiac resynchronization therapy. JACC Clin Electrophysiol. 2016;2(4):426\u201333.","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"751_CR39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/europace\/eus435","volume":"15","author":"B Thibault","year":"2013","unstructured":"Thibault B, Dubuc M, Khairy P, Guerra PG, Macle L, Rivard L, et al. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace. 2013;15(7):984\u201391.","journal-title":"Europace."},{"issue":"11","key":"751_CR40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cardfail.2013.10.003","volume":"19","author":"CA Rinaldi","year":"2013","unstructured":"Rinaldi CA, Kranig W, Leclercq C, Kacet S, Betts T, Bordachar P, et al. Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. J Card Fail. 2013;19(11):731\u20138.","journal-title":"J Card Fail"},{"issue":"7","key":"751_CR41","first-page":"1170","volume":"19","author":"GB Forleo","year":"2017","unstructured":"Forleo GB, Santini L, Giammaria M, Potenza D, Curnis A, Calabrese V, et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP). Europace. 2017;19(7):1170\u20137.","journal-title":"Europace."},{"key":"751_CR42","doi-asserted-by":"crossref","unstructured":"\u2022 Leclercq C, Burri H, Curnis A, Delnoy PP, Rinaldi CA, Sperzel J, et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. Eur Heart J. 2019. First large randomizedtrial comparing multipoint pacing to conventional bipolar pacing. The programming was at the physician\u2019s discretion in this first phase. Multipoint pacing did not increase reverse remodeling in initial CRT non-responders. In phase 2, a standardized programming protocol will be implemented.","DOI":"10.1093\/eurheartj\/ehz109"},{"issue":"9","key":"751_CR43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/europace\/eum140","volume":"9","author":"R Lenarczyk","year":"2007","unstructured":"Lenarczyk R, Kowalski O, Kukulski T, Szulik M, Pruszkowska-Skrzep P, Zielinska T, et al. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study. Europace. 2007;9(9):762\u20137.","journal-title":"Europace."},{"issue":"15","key":"751_CR44","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2007.11.074","volume":"51","author":"C Leclercq","year":"2008","unstructured":"Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, et al. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol. 2008;51(15):1455\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"751_CR45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jacep.2016.05.015","volume":"2","author":"R Providencia","year":"2016","unstructured":"Providencia R, Rogers D, Papageorgiou N, Ioannou A, James A, Babu G, et al. Long-term results of triventricular versus biventricular pacing in heart failure: a propensity-matched comparison. JACC Clin Electrophysiol. 2016;2(7):825\u201335.","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"751_CR46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.hrthm.2017.12.028","volume":"15","author":"P Bordachar","year":"2018","unstructured":"Bordachar P, Gras D, Clementy N, Defaye P, Mondoly P, Boveda S, et al. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: the V(3) trial. Heart Rhythm. 2018;15(6):870\u20136.","journal-title":"Heart Rhythm"},{"issue":"Suppl 3","key":"751_CR47","first-page":"iii88","volume":"10","author":"SS Barold","year":"2008","unstructured":"Barold SS, Ilercil A, Herweg B. Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. Europace. 2008;10(Suppl 3):iii88\u201395.","journal-title":"Europace"},{"key":"751_CR48","doi-asserted-by":"crossref","unstructured":"Pujol-Lopez M, San Antonio R, Mont L, Trucco E, Tolosana JM, Arbelo E, et al. Electrocardiographic optimization techniques in resynchronization therapy. Europace. 2019.","DOI":"10.1093\/europace\/euz126"},{"issue":"3","key":"751_CR49","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.ijcard.2013.01.216","volume":"168","author":"ZI Whinnett","year":"2013","unstructured":"Whinnett ZI, Francis DP, Denis A, Willson K, Pascale P, van Geldorp I, et al. Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice. Int J Cardiol. 2013;168(3):2228\u201337.","journal-title":"Int J Cardiol"},{"issue":"23","key":"751_CR50","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.CIR.99.23.2993","volume":"99","author":"A Auricchio","year":"1999","unstructured":"Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The pacing therapies for congestive heart failure study group. The Guidant congestive heart failure research group. Circulation. 1999;99(23):2993\u20133001.","journal-title":"Circulation."},{"issue":"25","key":"751_CR51","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/CIRCULATIONAHA.110.992552","volume":"122","author":"KA Ellenbogen","year":"2010","unstructured":"Ellenbogen KA, Gold MR, Meyer TE, Fernndez Lozano I, Mittal S, Waggoner AD, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122(25):2660\u20138.","journal-title":"Circulation."},{"issue":"6","key":"751_CR52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ahj.2010.02.034","volume":"159","author":"WT Abraham","year":"2010","unstructured":"Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS, Committee FS. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010;159(6):944\u20138e1.","journal-title":"Am Heart J"},{"issue":"12","key":"751_CR53","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2005.08.032","volume":"46","author":"AR Leon","year":"2005","unstructured":"Leon AR, Abraham WT, Brozena S, Daubert JP, Fisher WG, Gurley JC, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol. 2005;46(12):2298\u2013304.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"751_CR54","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1111\/j.1540-8159.2008.02267.x","volume":"32","author":"G Boriani","year":"2009","unstructured":"Boriani G, Biffi M, Muller CP, Seidl KH, Grove R, Vogt J, et al. A prospective randomized evaluation of VV delay optimization in CRT-D recipients: echocardiographic observations from the RHYTHM II ICD study. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S120\u20135.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"751_CR55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ahj.2012.07.026","volume":"164","author":"WT Abraham","year":"2012","unstructured":"Abraham WT, Leon AR, St John Sutton MG, Keteyian SJ, Fieberg AM, Chinchoy E, et al. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy. Am Heart J. 2012;164(5):735\u201341.","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"751_CR56","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1111\/j.1540-8159.2008.02294.x","volume":"32","author":"D Gras","year":"2009","unstructured":"Gras D, Gupta MS, Boulogne E, Guzzo L, Abraham WT. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S236\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"11","key":"751_CR57","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.hrthm.2012.07.009","volume":"9","author":"DO Martin","year":"2012","unstructured":"Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K, et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012;9(11):1807\u201314.","journal-title":"Heart Rhythm"},{"issue":"7","key":"751_CR58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ejhf.895","volume":"19","author":"G Filippatos","year":"2017","unstructured":"Filippatos G, Birnie D, Gold MR, Gerritse B, Hersi A, Jacobs S, et al. Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing. Eur J Heart Fail. 2017;19(7):950\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"751_CR59","first-page":"730","volume":"38","author":"J Brugada","year":"2017","unstructured":"\u2022 Brugada J, Delnoy PP, Brachmann J, Reynolds D, Padeletti L, Noelker G, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017;38(10):730\u20138 Large randomized trial illustrating the non-inferiority of the SonR algorithm compared to echo guided electrical delay optimization.","journal-title":"Eur Heart J"},{"issue":"4","key":"751_CR60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jacc.2008.09.043","volume":"53","author":"BA Koplan","year":"2009","unstructured":"Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53(4):355\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"751_CR61","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","volume":"8","author":"DL Hayes","year":"2011","unstructured":"Hayes DL, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Seth M, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8(9):1469\u201375.","journal-title":"Heart Rhythm"},{"issue":"5","key":"751_CR62","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/CIRCEP.112.973776","volume":"5","author":"A Cheng","year":"2012","unstructured":"Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol. 2012;5(5):884\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"751_CR63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCHEARTFAILURE.109.912683","volume":"3","author":"JT Heywood","year":"2010","unstructured":"Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, et al. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010;3(5):596\u2013605.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"751_CR64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cardfail.2017.03.001","volume":"23","author":"P Martens","year":"2017","unstructured":"\u2022 Martens P, Verbrugge FH, Nijst P, Bertrand PB, Dupont M, Tang WH, et al. Feasibility and association of neurohumoral blocker up-titration after cardiac resynchronization therapy. J Card Fail. 2017;23(8):597\u2013605 This retrospective analysis indicates that neurohromonal uptitration after CRT implantation is often feasable and is associated with improved outcomes.","journal-title":"J Card Fail"},{"issue":"2","key":"751_CR65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjcard.2017.04.021","volume":"120","author":"P Martens","year":"2017","unstructured":"Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W. Changes in loop diuretic dose and outcome after cardiac resynchronization therapy in patients with heart failure and reduced left ventricular ejection fractions. Am J Cardiol. 2017;120(2):267\u201373.","journal-title":"Am J Cardiol"},{"issue":"16","key":"751_CR66","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/eurheartj\/eht514","volume":"35","author":"S Schmidt","year":"2014","unstructured":"Schmidt S, Hurlimann D, Starck CT, Hindricks G, Luscher TF, Ruschitzka F, et al. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. Eur Heart J. 2014;35(16):1051\u201360.","journal-title":"Eur Heart J"},{"issue":"11","key":"751_CR67","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.amjcard.2012.01.387","volume":"109","author":"L Mantziari","year":"2012","unstructured":"Mantziari L, Guha K, Khalique Z, McDonagh T, Sharma R. Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis. Am J Cardiol. 2012;109(11):1619\u201325.","journal-title":"Am J Cardiol"},{"issue":"3","key":"751_CR68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ehjcvp\/pvv016","volume":"1","author":"CT Witt","year":"2015","unstructured":"Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival. Eur Heart J Cardiovasc Pharmacother. 2015;1(3):182\u20138.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"3","key":"751_CR69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjcard.2011.03.060","volume":"108","author":"W Mullens","year":"2011","unstructured":"Mullens W, Kepa J, De Vusser P, Vercammen J, Rivero-Ayerza M, Wagner P, et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol. 2011;108(3):409\u201315.","journal-title":"Am J Cardiol"},{"issue":"14","key":"751_CR70","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","volume":"301","author":"CM O'Connor","year":"2009","unstructured":"O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439\u201350.","journal-title":"JAMA."},{"issue":"27","key":"751_CR71","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"1","key":"751_CR72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/HJR.0b013e32801164b3","volume":"14","author":"VM Conraads","year":"2007","unstructured":"Conraads VM, Vanderheyden M, Paelinck B, Verstreken S, Blankoff I, Miljoen H, et al. The effect of endurance training on exercise capacity following cardiac resynchronization therapy in chronic heart failure patients: a pilot trial. Eur J Cardiovasc Prev Rehabil. 2007;14(1):99\u2013106.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"25","key":"751_CR73","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.jacc.2009.02.063","volume":"53","author":"AY Patwala","year":"2009","unstructured":"Patwala AY, Woods PR, Sharp L, Goldspink DF, Tan LB, Wright DJ. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training: a randomized controlled study. J Am Coll Cardiol. 2009;53(25):2332\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"751_CR74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cardfail.2014.10.004","volume":"21","author":"EP Zeitler","year":"2015","unstructured":"Zeitler EP, Piccini JP, Hellkamp AS, Whellan DJ, Jackson KP, Ellis SJ, et al. Exercise training and pacing status in patients with heart failure: results from HF-ACTION. J Card Fail. 2015;21(1):60\u20137.","journal-title":"J Card Fail"},{"issue":"6","key":"751_CR75","doi-asserted-by":"crossref","first-page":"e12467","DOI":"10.1111\/1755-5922.12467","volume":"36","author":"P Martens","year":"2018","unstructured":"Martens P, Jacobs G, Dupont M, Mullens W. Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy. Cardiovasc Ther. 2018;36(6):e12467.","journal-title":"Cardiovasc Ther"},{"issue":"9943","key":"751_CR76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","volume":"384","author":"G Hindricks","year":"2014","unstructured":"Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583\u201390.","journal-title":"Lancet"},{"issue":"3","key":"751_CR77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ejhf.626","volume":"19","author":"G Boriani","year":"2017","unstructured":"Boriani G, Da Costa A, Quesada A, Ricci RP, Favale S, Boscolo G, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"10152","key":"751_CR78","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(18)31880-4","volume":"392","author":"F Koehler","year":"2018","unstructured":"Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B-A, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392(10152):1047\u201357.","journal-title":"Lancet"},{"issue":"1","key":"751_CR79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","volume":"16","author":"VM van Deursen","year":"2014","unstructured":"van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16(1):103\u201311.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"751_CR80","doi-asserted-by":"crossref","first-page":"e004646","DOI":"10.1161\/CIRCHEARTFAILURE.117.004646","volume":"11","author":"A Sharma","year":"2018","unstructured":"Sharma A, Zhao X, Hammill BG, Hernandez AF, Fonarow GC, Felker GM, et al. Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the get with the guidelines-heart failure registry. Circ Heart Fail. 2018;11(6):e004646.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"751_CR81","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","volume":"42","author":"JB Braunstein","year":"2003","unstructured":"Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"751_CR82","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cardfail.2012.09.003","volume":"18","author":"FH Verbrugge","year":"2012","unstructured":"Verbrugge FH, Dupont M, Rivero-Ayerza M, de Vusser P, Van Herendael H, Vercammen J, et al. Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling. J Card Fail. 2012;18(11):845\u201353.","journal-title":"J Card Fail"},{"issue":"1","key":"751_CR83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amjcard.2016.09.017","volume":"119","author":"P Martens","year":"2017","unstructured":"Martens P, Verbrugge F, Nijst P, Dupont M, Tang WH, Mullens W. Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy. Am J Cardiol. 2017;119(1):65\u201370.","journal-title":"Am J Cardiol"},{"issue":"1","key":"751_CR84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCGENETICS.109.871236","volume":"3","author":"G Agnetti","year":"2010","unstructured":"Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, et al. Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet. 2010;3(1):78\u201387.","journal-title":"Circ Cardiovasc Genet"},{"key":"751_CR85","doi-asserted-by":"crossref","unstructured":"Galand V, Singh JP, Leclercq C. Alternative left ventricular pacing approaches for optimal cardiac resynchronization therapy. Heart Rhythm. 2019.","DOI":"10.1016\/j.hrthm.2019.03.011"},{"issue":"10","key":"751_CR86","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2010.04.038","volume":"56","author":"P Bordachar","year":"2010","unstructured":"Bordachar P, Derval N, Ploux S, Garrigue S, Ritter P, Haissaguerre M, et al. Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol. 2010;56(10):747\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"751_CR87","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2009.08.045","volume":"55","author":"N Derval","year":"2010","unstructured":"Derval N, Steendijk P, Gula LJ, Deplagne A, Laborderie J, Sacher F, et al. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol. 2010;55(6):566\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"751_CR88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/europace\/eut420","volume":"16","author":"AK Shetty","year":"2014","unstructured":"Shetty AK, Sohal M, Chen Z, Ginks MR, Bostock J, Amraoui S, et al. A comparison of left ventricular endocardial, multisite, and multipolar epicardial cardiac resynchronization: an acute haemodynamic and electroanatomical study. Europace. 2014;16(6):873\u20139.","journal-title":"Europace."},{"issue":"27","key":"751_CR89","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1093\/eurheartj\/ehv723","volume":"37","author":"JM Morgan","year":"2016","unstructured":"\u2022 Morgan JM, Biffi M, Geller L, Leclercq C, Ruffa F, Tung S, et al. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. Eur Heart J. 2016;37(27):2118\u201327 Prospective study describing safety of an endocardial LV lead system in patients with failed conventional implant. There was a significant incidence of transient ischemic attack and stroke despite oral anticoagulant thereapy.","journal-title":"Eur Heart J"},{"issue":"17","key":"751_CR90","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jacc.2017.02.059","volume":"69","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Miller MA, Neuzil P, Sogaard P, Butter C, Seifert M, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol. 2017;69(17):2119\u201329.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"751_CR91","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.56.6.996","volume":"56","author":"OS Narula","year":"1977","unstructured":"Narula OS. Longitudinal dissociation in the His bundle. Bundle branch block due to asynchronous conduction within the His bundle in man. Circulation. 1977;56(6):996\u20131006.","journal-title":"Circulation."},{"issue":"24","key":"751_CR92","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.jacc.2018.09.073","volume":"72","author":"AD Arnold","year":"2018","unstructured":"Arnold AD, Shun-Shin MJ, Keene D, Howard JP, Sohaib SMA, Wright IJ, et al. His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2018;72(24):3112\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"751_CR93","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Upadhyay GA, Vijayaraman P, Nayak HM, Verma N, Dandamudi G, Sharma PS, et al. His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol. 2019. First small randomized controlled trial comparing His-bundle pacing to conventional CRT in first implants. In the intention to treat analysis, there was no difference in terms of reverse remodelling or heart failure hospitalization or death after median of 6.2 months fo follow-up. However, there was a high cross-ove rrate.","DOI":"10.1016\/j.jacc.2019.04.026"},{"key":"751_CR94","doi-asserted-by":"crossref","unstructured":"Upadhyay GA, Vijayaraman P, Nayak HM, Verma N, Dandamudi G, Sharma PS, et al. On-treatment comparison between corrective his bundle pacing and biventricular pacing for cardiac resynchronization: a secondary analysis of his-sync. Heart Rhythm 2019.","DOI":"10.1016\/j.hrthm.2019.05.009"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-019-0751-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T14:33:20Z","timestamp":1664030000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-019-0751-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s11936-019-0751-2","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"25 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"45"}}